DSCSA software or a readiness binder: what an independent pharmacy is actually buying

Search for DSCSA help as an independent pharmacy and you land on two kinds of company that look, from the outside, like the same company. Both name the same statute. Both name the same date. Both promise compliance. They are not competing for the same problem, and the reason matters more than any feature list: §582(g)(1) is six obligations, not one, and they split cleanly down the middle between data and documentation.

What the software actually does

InfiniTrak describes itself as “an all-in-one compliance solution designed specifically for dispensers,” and its distinguishing claim is integration: “the only DSCSA software integrated with BestRx, PrimeRx, PioneerRx, Liberty Software and 30 more leading pharmacy management systems.” That is a real and specific thing to sell. If your problem is that serialized transaction data arrives from four wholesalers in four shapes and never reaches your dispensing system, an integration is what fixes it.

LSPedia is built wider, an EPCIS serialization platform whose OneScan suite runs across manufacturers, wholesalers, 3PLs, hospitals and dispensers, with modules for verification router service, authorized-trading-partner connections, suspect order monitoring and returns. A pharmacy is one customer type among several on a supply-chain-wide product.

Neither is a bad purchase. Both do something DoseTrace does not do and does not claim to do: they move, host and reconcile serialized transaction data. If that is your gap, buy one of them. This page will not pretend otherwise.

The half that no platform produces

Read the FDA’s own exemption letters and something is conspicuously absent. Neither tells a pharmacy to buy anything. The word vendor does not appear in either. The word software appears exactly once across both, in the 6 August 2026 letter, and it describes an obligation on FDA rather than on you: section 582(g)(3) requires the agency to contract an independent consulting company to conduct “a technology and software assessment” of whether package-level tracing is feasible for dispensers your size. That unfinished assessment is the stated reason the deadline moved to 27 November 2027. The phrase the statute uses for what you must have, quoted by the FDA obligation by obligation, is “systems and processes.”

That wording is doing work. Obligation (D) is for “systems and processes necessary to promptly respond with the transaction information and transaction statement for a product upon a request by the Secretary, or other appropriate Federal or State official, in the event of a recall or for the purposes of investigating a suspect product or an illegitimate product.” A platform can hold the data. It cannot tell an inspector who in your pharmacy answers that request on a Tuesday, from which system, inside what turnaround, or show that the person concerned was trained. That is a written procedure, and its absence is what an inspection surfaces.

The same is true of (E) and (F). We walk all six obligations one at a time with the FDA’s language attached to each.

Which half is missing, a two-question test

• Can you retrieve the transaction information for a specific NDC and lot from every wholesaler you buy from, today, without calling anyone? If no, that is a data gap. Software or a wholesaler portal connection closes it.
• If a state board inspector asked this afternoon, could you hand over a dated exemption determination, a trading-partner verification log, your suspect-product SOP and a training attestation? If no, that is a documentation gap. No amount of serialized data closes it, because nothing in the platform is the record.

Most independents we hear from answer yes to the first and no to the second. The serialized data was already flowing, it was generated upstream and delivered into a portal, while the written half was never written, because nobody sells it and it does not demo well.

Cost, and why it is hard to compare

As of 7 August 2026, neither InfiniTrak nor LSPedia publishes a price on its website. Both route to a conversation, a demo request in InfiniTrak’s case, “Contact Sales” in LSPedia’s. That is normal for platform software, where the number depends on store count, systems and modules, and it means a like-for-like comparison here would be invention. We are not going to publish a number for someone else’s product.

One company in the wider market does publish a fee table: the DSCSA360 program from PRS Pharmacy Services and Advasur is $115/month per location for a community pharmacy, $83 discounted. That is a compliance program rather than a track-and-trace platform, so it is not a like-for-like comparison with either vendor above, but it is a real number and we set it beside ours in full.

What we can publish is ours. A DoseTrace binder is $99 flat, one time, from a 15-minute intake. No subscription, no per-store multiplier, no integration. It is also worth naming the shape of the difference: platform compliance is a recurring operating cost you carry for as long as you dispense; the written record is a fixed piece of work you do once and then maintain.

They are not substitutes

The honest version: if you buy a platform and never write the procedures, you have bought half. If you buy the binder and cannot reach your transaction data, you have bought the other half. Some pharmacies genuinely need both. Many independents buying from a single primary wholesaler need only the second, and are being quoted for the first because that is what the market sells.

One thing to check before you spend anything: which exemption track you are actually on. If your company employs 26 or more full-time pharmacists and technicians, the relief you may think runs to November 2026 ran only to November 2025 and has already expired. That count is taken across the whole owning company, not per store , the most common misreading of the exemption and the one that changes what you need to buy.

Where DoseTrace fits

DoseTrace is not an EPCIS or serialization platform. We do not move, host or transmit transaction data, and (A), (B) and (C) stay with your wholesaler and your existing systems. What we produce is the nine-document readiness binder that covers the written half, the exemption determination with the count behind it, the trading-partner verification log, the standard operating procedures, the tracing response runbook, the training attestation and the retention plan, each one dated.

Two follow-on questions come up at this point, and each has its own page. If you are weighing buying either half against having someone prepare it, six kinds of organisation prepare DSCSA documentation for independent pharmacies , including the free option your own trade associations run. And if the platform half is already covered because your distributor moves the data, a wholesaler handling DSCSA still leaves three duties with you.

Check which exemption track you are on, free, about a minute, and it stores nothing. Contact reaches a person.

Statutory quotations are from the FDA document DSCSA Exemptions from Certain Requirements Under Section 582 of the FD&C Act for Small Business Dispensers Until November 27, 2027, issued 6 August 2026, the letter that now grants the small-dispenser exemption, and which FDA republished at the address previously serving the 12 July 2024 version, cross-checked against the 9 October 2024 letter for certain trading partners. Both retrieved and verified 11 August 2026. Descriptions of InfiniTrak and LSPedia are quoted from infinitrak.us and lspedia.com as retrieved on 7 August 2026, when neither site carried a dollar figure and both /pricing routes returned 404. The DSCSA360 fee table is from Attachment B of the service agreement at dscsa.prsrxnetwork.com, also retrieved 7 August 2026; it replaces the “as low as $66/month” figure previously quoted here, which PRS removed from its product page between 5 and 7 August 2026. All three are independent companies with no relationship to DoseTrace, and their sites are the authority on their own products. DoseTrace is not a law firm and nothing here is legal advice.